Relationship between metformin and abdominal aortic aneurysm

被引:29
作者
Raffort, Juliette [1 ,2 ]
Hassen-Khodja, Reda [2 ,3 ]
Jean-Baptiste, Elixene [2 ,3 ]
Lareyre, Fabien [2 ,3 ]
机构
[1] Univ Hosp Nice, Dept Clin Biochem, 30 Ave Voie Romaine, F-06001 Nice, France
[2] Univ Hosp Nice, Dept Vasc Surg, Nice, France
[3] Univ Cote Azur, CHU, INSERM, C3M, Nice, France
关键词
Abdominal aortic aneurysm; Metformin; Biguanide; Antidiabetic drug; Clinical trial; COMPUTED-TOMOGRAPHY; ANGIOTENSIN-II; DOUBLE-BLIND; ULTRASOUND; DIAMETER; ARTERIES; GROWTH; WOMEN; RISK; DRUG;
D O I
10.1016/j.jvs.2019.08.270
中图分类号
R61 [外科手术学];
学科分类号
摘要
Abdominal aortic aneurysm (AAA) is a life-threatening disease and pharmacologic agents to treat the disease remain lacking for clinical practice. Epidemiologic studies have highlighted a negative association between the use of antidiabetic drugs, including metformin, and AAA. Metformin is well-known for its blood glucose-lowering effect, but its action on both metabolism and inflammatory response has led to propose it as a potential therapeutic target in several cardiovascular diseases. In this review, we summarize the current knowledge on the link between metformin and AAA. Based on the known effects of the drug on the aortic wall, translational applications and clinical trials investigating the interest of metformin in the management of patients with AAA are discussed.
引用
收藏
页码:1056 / 1062
页数:7
相关论文
共 44 条
[1]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc11-S062, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc13-S011, 10.2337/dc10-S011, 10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc12-s064]
[2]   Metformin attenuates fluctuating glucose-induced endothelial dysfunction through enhancing GTPCH1-mediated eNOS recoupling and inhibiting NADPH oxidase [J].
An, Huijie ;
Wei, Rui ;
Ke, Jing ;
Yang, Jin ;
Liu, Ye ;
Wang, Xian ;
Wang, Guang ;
Hong, Tianpei .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (06) :1017-1024
[3]  
[Anonymous], 2015, LANCET, DOI DOI 10.1016/S0140-6736(15)60401-9
[4]   Reduced Long-Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide Observational Study [J].
Avdic, Tarik ;
Franzen, Stefan ;
Zarrouk, Moncef ;
Acosta, Stefan ;
Nilsson, Peter ;
Gottsater, Anders ;
Svensson, Ann-Marie ;
Gudbjornsdottir, Soffia ;
Eliasson, Bjorn .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (03)
[5]  
Azuma Junya, 2009, J Vis Exp, DOI 10.3791/1280
[6]   Reproducibility of ultrasound measurement of the abdominal aorta [J].
Beales, L. ;
Wolstenhulme, S. ;
Evans, J. A. ;
West, R. ;
Scott, D. J. A. .
BRITISH JOURNAL OF SURGERY, 2011, 98 (11) :1517-1525
[7]   The care of patients with an abdominal aortic aneurysm: The Society for Vascular Surgery practice guidelines [J].
Chaikof, Elliot L. ;
Brewster, David C. ;
Dalman, Ronald L. ;
Makaroun, Michel S. ;
Illig, Karl A. ;
Sicard, Gregorio A. ;
Timaran, Carlos H. ;
Upchurch, Gilbert R., Jr. ;
Veith, Frank J. .
JOURNAL OF VASCULAR SURGERY, 2009, 50 :2S-49S
[8]   Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management [J].
Chaudhury, Arun ;
Duvoor, Chitharanjan ;
Dendi, Vijaya Sena Reddy ;
Kraleti, Shashank ;
Chada, Aditya ;
Ravilla, Rahul ;
Marco, Asween ;
Shekhawat, Nawal Singh ;
Montales, Maria Theresa ;
Kuriakose, Kevin ;
Sasapu, Appalanaidu ;
Beebe, Alexandria ;
Patil, Naveen ;
Musham, Chaitanya K. ;
Lohani, Govinda Prasad ;
Mirza, Wasique .
FRONTIERS IN ENDOCRINOLOGY, 2017, 8
[9]   Metformin and its clinical use: new insights for an old drug in clinical practice [J].
Cicero, Arrigo F. G. ;
Tartagni, Elisa ;
Ertek, Sibel .
ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (05) :907-917
[10]   Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice [J].
Daugherty, A ;
Manning, MW ;
Cassis, LA .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1605-1612